-
1.
公开(公告)号:US20140271463A1
公开(公告)日:2014-09-18
申请号:US14207396
申请日:2014-03-12
Applicant: Stichting VU-VUmc
IPC: C07K16/28 , A61K51/10 , G01N33/569
CPC classification number: C07K16/28 , A61K51/1018 , A61K51/1027 , C07K14/4711 , G01N33/56966 , G01N33/6896 , G01N2800/2821 , G01N2800/50
Abstract: The disclosure relates to the use of altered BRI2 levels as a biomarker for the risk of developing Alzheimer's disease. Novel treatments based on altered BRI2 levels and anti-BRI2 antibodies are also provided.
Abstract translation: 本公开涉及使用改变的BRI2水平作为发展阿尔茨海默病的风险的生物标志物。 还提供了基于改变的BRI2水平和抗BRI2抗体的新型治疗。